| Tue, Jul 7, 2009 | | • | OXIGENE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, F
EDGAR Online (Tue, Jul 7)
| | Mon, Jul 6, 2009 | | • | OXiGENE Announces Agreement to Acquire Symphony ViDA, Including More Than $12 Million in Unrestricted Cash and All Rights to OXi4503 and ZYBRESTAT for Ophthalmology
GlobeNewswire (Mon, Jul 6)
| | Thu, Jun 25, 2009 | | • | OXiGENE Initiates Phase 2 Trial of ZYBRESTAT for Ophthalmology
GlobeNewswire (Thu, Jun 25)
| | Wed, Jun 17, 2009 | | • | OXIGENE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Jun 17)
| | • | OXiGENE Appoints Dr. Peter J. Langecker as Chief Development Officer
GlobeNewswire (Wed, Jun 17)
| | Tue, Jun 2, 2009 | | • | 10 Stocks to Shake the Market
at Motley Fool (Tue, Jun 2)
| | Mon, Jun 1, 2009 | | • | OXIGENE INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Jun 1)
| | • | OXiGENE Reports Positive Data From Phase 2 Trial of ZYBRESTAT in Platinum Resistant Ovarian Cancer At the 2009 ASCO Annual Meeting
GlobeNewswire (Mon, Jun 1)
| | Sun, May 31, 2009 | | • | [video] Five Biotech Stocks to Watch
at TheStreet.com (Sun, May 31)
| | • | [video] 5 Hot Biotech Stocks to Watch
at TheStreet.com (Sun, May 31)
| | Thu, May 28, 2009 | | • | [video] Biotalk: Getting ready for ASCO
at TheStreet.com (Thu, May 28)
| | • | Small-Cap Biotechs Pop Before Conference
at TheStreet.com (Thu, May 28)
| | Tue, May 26, 2009 | | • | [video] 5 Hot Biotech Stocks to Watch
at TheStreet.com (Tue, May 26)
| | Thu, May 21, 2009 | | • | OXiGENE Announces Clinical Data to be Presented At the 2009 Annual Meeting of the American Society of Clinical Oncology
GlobeNewswire (Thu, May 21)
| | Mon, May 11, 2009 | | • | OXIGENE INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, May 11)
| | • | OXiGENE Reports First Quarter 2009 Financial Results
GlobeNewswire (Mon, May 11)
| | Mon, May 4, 2009 | | • | OXIGENE INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, May 4)
| | • | OXiGENE Announces First Quarter 2009 Earnings Conference Call and Webcast
GlobeNewswire (Mon, May 4)
| | Wed, Apr 22, 2009 | | • | OXiGENE Reports Preclinical Data for OXi4503 Showing Pronounced Antitumor Activity in Animal Studies in Acute Myeloid Leukemia At the American Association of Cancer Research Annual Meeting
GlobeNewswire (Wed, Apr 22)
| | Mon, Apr 6, 2009 | | • | OXiGENE Begins Phase 1b/2a Trial of OXi4503, a Novel Second-Generation Vascular Disrupting Agent
GlobeNewswire (Mon, Apr 6)
| | Fri, Apr 3, 2009 | | • | OXIGENE INC Financials
EDGAR Online Financials (Fri, Apr 3)
| | Mon, Mar 30, 2009 | | • | OXiGENE Receives Qualified Opinion On Its Audited Financial Statements for 2008
GlobeNewswire (Mon, Mar 30)
| | • | OXIGENE INC Files SEC form 10-K, Annual Report
EDGAR Online (Mon, Mar 30)
| | Wed, Mar 25, 2009 | | • | OXIGENE INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Mar 25)
| | Thu, Mar 19, 2009 | | • | OXIGENE INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Mar 19)
|
Add OXGN News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
Headlines
